Lee Financial Co - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 7 filers reported holding CRISPR THERAPEUTICS AG in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Lee Financial Co ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2023$2,724
-19.1%
600.0%0.00%0.0%
Q2 2023$3,369
+24.1%
600.0%0.00%
Q1 2023$2,714
+11.3%
600.0%0.00%
Q4 2022$2,439
-39.0%
600.0%0.00%
-100.0%
Q3 2022$4,0000.0%600.0%0.00%0.0%
Q2 2022$4,0000.0%600.0%0.00%0.0%
Q1 2022$4,000
-20.0%
600.0%0.00%0.0%
Q4 2021$5,000
-28.6%
600.0%0.00%0.0%
Q3 2021$7,000
-30.0%
600.0%0.00%
-50.0%
Q2 2021$10,000
+42.9%
600.0%0.00%0.0%
Q1 2021$7,000
-22.2%
600.0%0.00%0.0%
Q4 2020$9,000
-86.2%
60
-92.3%
0.00%
-88.9%
Q3 2020$65,000
+14.0%
7800.0%0.02%
+12.5%
Q2 2020$57,000
+1800.0%
780
+1200.0%
0.02%
+1500.0%
Q1 2020$3,000
-25.0%
600.0%0.00%0.0%
Q4 2019$4,000
+100.0%
600.0%0.00%
Q3 2019$2,000
-33.3%
600.0%0.00%
-100.0%
Q2 2019$3,000
+50.0%
600.0%0.00%
Q1 2019$2,0000.0%600.0%0.00%
-100.0%
Q4 2018$2,000
-33.3%
600.0%0.00%0.0%
Q3 2018$3,000
-25.0%
600.0%0.00%0.0%
Q2 2018$4,000600.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q4 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 498,558$32,581,00055.55%
NEA Management Company, LLC 1,590,002$103,907,0005.19%
ARK Investment Management 8,237,122$538,296,0003.75%
Nikko Asset Management Americas, Inc. 4,262,736$277,078,0003.54%
CLOUGH CAPITAL PARTNERS L P 414,767$27,105,0002.89%
Integral Health Asset Management, LLC 220,000$14,377,0002.79%
PLUSTICK MANAGEMENT LLC 50,000$3,268,0002.48%
HC Advisors, LLC 53,944$3,525,0002.43%
Green Alpha Advisors, LLC 27,466$1,795,0001.52%
EFG Asset Management (North America) Corp. 84,356$5,516,0001.28%
View complete list of CRISPR THERAPEUTICS AG shareholders